Literature DB >> 23212597

Radioembolisation for treatment of pediatric hepatocellular carcinoma.

Clifford Matthew Hawkins1, Kamlesh Kukreja, James I Geller, Carmen Schatzman, Ross Ristagno.   

Abstract

Transarterial radioembolisation with yttrium-90 (TARE-Y90), a catheter-directed therapy, has been used extensively in adults to treat primary and secondary hepatic malignancies. To our knowledge, the use of this palliative technique has not been described in children. We present two children with unresectable hepatocellular carcinoma (HCC) treated with TARE-Y90.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23212597     DOI： 10.1007/s00247-012-2568-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  15 in total

1.  Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma.

Authors:  Chia-Wei Yang; Hsu-Heng Yen; Wei-Wen Su; Yang-Yuan Chen; Maw-Soan Soon
Journal:  South Med J       Date:  2010-12       Impact factor: 0.954

2.  Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

Authors:  Riad Salem; Robert J Lewandowski; Bassel Atassi; Stuart C Gordon; Vanessa L Gates; Omar Barakat; Ziad Sergie; Ching-Yee O Wong; Kenneth G Thurston
Journal:  J Vasc Interv Radiol       Date:  2005-12       Impact factor: 3.464

3.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

4.  A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.

Authors:  R J Lewandowski; L M Kulik; A Riaz; S Senthilnathan; M F Mulcahy; R K Ryu; S M Ibrahim; K T Sato; T Baker; F H Miller; R Omary; M Abecassis; R Salem
Journal:  Am J Transplant       Date:  2009-06-22       Impact factor: 8.086

5.  A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma.

Authors:  Delia D'Avola; Mercedes Lñarrairaegui; Jose I Bilbao; Antonio Martinez-Cuesta; Felix Alegre; Jose I Herrero; Jorge Quiroga; Jesus Prieto; Bruno Sangro
Journal:  Hepatogastroenterology       Date:  2009 Nov-Dec

Review 6.  Transcatheter intraarterial therapies: rationale and overview.

Authors:  Robert J Lewandowski; Jean-Francois Geschwind; Eleni Liapi; Riad Salem
Journal:  Radiology       Date:  2011-06       Impact factor: 11.105

7.  Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Authors:  David A Kooby; Vasili Egnatashvili; Swetha Srinivasan; Abbas Chamsuddin; Keith A Delman; John Kauh; Charles A Staley; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2009-12-21       Impact factor: 3.464

8.  Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.

Authors:  Brian I Carr; Venkateswarlu Kondragunta; Shama C Buch; Robert A Branch
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

9.  Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.

Authors:  Andrew S Kennedy; Patrick McNeillie; William A Dezarn; Charles Nutting; Bruno Sangro; Dan Wertman; Michael Garafalo; David Liu; Douglas Coldwell; Michael Savin; Tobias Jakobs; Steven Rose; Richard Warner; Dennis Carter; Stephen Sapareto; Subir Nag; Seza Gulec; Allison Calkins; Vanessa L Gates; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-20       Impact factor: 7.038

10.  Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group.

Authors:  P Czauderna; G Mackinlay; G Perilongo; J Brown; E Shafford; D Aronson; J Pritchard; P Chapchap; J Keeling; J Plaschkes; J B Otte
Journal:  J Clin Oncol       Date:  2002-06-15       Impact factor: 44.544
View more
  4 in total

Review 1.  Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.

Authors:  Matthew P Lungren; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh Thakor; Richard B Towbin; Anne Marie Cahill; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2018-01-23

Review 2.  Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Hong-Liang Sun; Yao-Ting Chen
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 3.  Unresectable hepatoblastoma: current perspectives.

Authors:  Angela D Trobaugh-Lotrario; Rebecka L Meyers; Allison F O'Neill; James H Feusner
Journal:  Hepat Med       Date:  2017-02-01

Review 4.  Endovascular approaches in pediatric interventional oncology.

Authors:  Raja Shaikh; Fernando Gomez Munoz
Journal:  CVIR Endovasc       Date:  2021-01-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.